Cingulate Inc. SEC filings CING

Cingulate Inc. has 493 filings in SEC EDGAR's recent list, going back to May 24, 2021. Its latest annual report, Form ARS, was filed on May 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 2, 2026 (officer or director change). The company's fiscal year ends on December 31.

Cingulate Inc. SEC filings
Form Description Filed Period
4 Insider transaction Oct 2, 2026 Sep 30, 2026
8-K Current report
Officer or director change
Oct 2, 2026 Sep 30, 2026
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 13, 2026 Aug 13, 2026
8-K Current report
Officer or director change
Jul 23, 2026 Jul 17, 2026
4 Insider transaction Jul 20, 2026 Jul 16, 2026
4 Insider transaction Jul 20, 2026 Jul 16, 2026
4 Insider transaction Jul 20, 2026 Jul 16, 2026
4 Insider transaction Jul 20, 2026 Jul 16, 2026
4 Insider transaction Jul 20, 2026 Jul 16, 2026
4 Insider transaction Jul 20, 2026 Jul 16, 2026
4 Insider transaction Jul 20, 2026 Jul 16, 2026
4 Insider transaction Jul 20, 2026 Jul 16, 2026
S-8 Employee stock plan registration Jul 15, 2026 —
8-K Current report
Officer or director change, Shareholder vote results
Jul 14, 2026 Jul 9, 2026
4 Insider transaction Jul 2, 2026 Jun 30, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Jul 2, 2026 Jun 30, 2026
8-K Current report
Regulation FD disclosure
Jun 16, 2026 Jun 16, 2026
4 Insider transaction Jun 8, 2026 Feb 13, 2026
3 Initial insider ownership Jun 8, 2026 Feb 13, 2026
8-K Current report
Regulation FD disclosure, Other events
Jun 2, 2026 Jun 2, 2026
DEF 14A Proxy statement May 29, 2026 May 29, 2026
ARS Annual report to shareholders May 29, 2026 Dec 31, 2025
DEFA14A Additional proxy material May 29, 2026 —
8-K Current report
Officer or director change
May 19, 2026 May 18, 2026
PRE 14A Preliminary proxy statement May 18, 2026 May 18, 2026
10-Q Quarterly report May 14, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 14, 2026 May 14, 2026
4 Insider transaction May 8, 2026 Mar 31, 2026
424B3 Prospectus Apr 28, 2026 —
EFFECT Filing Apr 24, 2026 —
CORRESP Letter to the SEC Apr 22, 2026 —
UPLOAD Letter from the SEC Apr 17, 2026 —
S-3 Shelf registration Apr 14, 2026 —
8-K Current report
Officer or director change
Apr 2, 2026 Mar 27, 2026
424B3 Prospectus Mar 27, 2026 —
EFFECT Filing Mar 26, 2026 —
SCHEDULE 13D/A Amended ownership over 5% (active) Mar 26, 2026 —
CORRESP Letter to the SEC Mar 26, 2026 —
EFFECT Filing Mar 24, 2026 —
8-K Current report
Material agreement, Shareholder vote results
Mar 24, 2026 Mar 24, 2026
424B3 Prospectus Mar 24, 2026 —
UPLOAD Letter from the SEC Mar 24, 2026 —
CORRESP Letter to the SEC Mar 23, 2026 —
S-3/A Filing Mar 23, 2026 —
S-3 Shelf registration Mar 20, 2026 —
DEFA14A Additional proxy material Mar 18, 2026 —
10-K Annual report Mar 18, 2026 Dec 31, 2025
8-K Current report
Results of operations, Other events
Mar 18, 2026 Mar 18, 2026
4 Insider transaction Mar 11, 2026 Mar 9, 2026
4 Insider transaction Mar 11, 2026 Mar 9, 2026
4 Insider transaction Mar 11, 2026 Mar 9, 2026
4 Insider transaction Mar 11, 2026 Mar 9, 2026
4 Insider transaction Mar 11, 2026 Mar 9, 2026
DEF 14A Proxy statement Mar 2, 2026 Mar 2, 2026
PRE 14A Preliminary proxy statement Feb 18, 2026 Feb 18, 2026
8-K Current report
Unregistered share sale, Officer or director change, Regulation FD disclosure, Other events
Feb 17, 2026 Feb 13, 2026
4 Insider transaction Feb 10, 2026 Feb 6, 2026
4 Insider transaction Feb 10, 2026 Feb 6, 2026
4 Insider transaction Feb 10, 2026 Feb 6, 2026
4 Insider transaction Feb 10, 2026 Feb 6, 2026
SCHEDULE 13D Ownership over 5% (active) Feb 9, 2026 —
8-K Current report
Unregistered share sale, Other events
Feb 6, 2026 Feb 6, 2026
8-K Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change
Jan 28, 2026 Jan 27, 2026
8-K Current report
Other events
Jan 15, 2026 Jan 12, 2026
UPLOAD Letter from the SEC Jan 14, 2026 —
S-3 Shelf registration Jan 12, 2026 —
424B5 Prospectus supplement Jan 12, 2026 —
4 Insider transaction Jan 5, 2026 Dec 31, 2025
8-K Current report
Unregistered share sale
Jan 2, 2026 Dec 23, 2025
8-K Current report
Officer or director change
Dec 15, 2025 Dec 15, 2025
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 13, 2025 Nov 13, 2025
4 Insider transaction Nov 10, 2025 Sep 30, 2025
4 Insider transaction Nov 10, 2025 Nov 3, 2025
3 Initial insider ownership Nov 10, 2025 Nov 3, 2025
8-K Current report
Material agreement, New debt, Regulation FD disclosure
Nov 10, 2025 Nov 7, 2025
8-K Current report
Regulation FD disclosure, Other events
Oct 14, 2025 Oct 14, 2025
8-K Current report
Shareholder vote results
Sep 25, 2025 Sep 25, 2025
8-K Current report
Unregistered share sale
Sep 5, 2025 Aug 29, 2025
8-K Current report
Officer or director change
Aug 28, 2025 Aug 22, 2025
10-Q Quarterly report Aug 19, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 19, 2025 Aug 19, 2025
DEF 14A Proxy statement Aug 15, 2025 Aug 15, 2025
NT 10-Q Filing Aug 15, 2025 Jun 30, 2025
8-K Current report
Officer or director change
Aug 15, 2025 Aug 14, 2025
8-K Current report
Officer or director change
Aug 8, 2025 Aug 7, 2025
8-K Current report
Regulation FD disclosure, Other events
Aug 6, 2025 Aug 6, 2025
PRE 14A Preliminary proxy statement Aug 5, 2025 Aug 5, 2025
424B3 Prospectus Jul 30, 2025 —
EFFECT Filing Jul 29, 2025 —
CORRESP Letter to the SEC Jul 25, 2025 —
S-8 Employee stock plan registration Jul 25, 2025 —
S-1/A Amended registration statement Jul 25, 2025 —
8-K Current report
Unregistered share sale
Jul 25, 2025 Jul 21, 2025
UPLOAD Letter from the SEC Jul 24, 2025 —
S-1 Registration statement Jul 22, 2025 —
8-K Current report
Material agreement, Unregistered share sale
Jul 22, 2025 Jul 21, 2025
4 Insider transaction Jul 10, 2025 Jul 8, 2025
3 Initial insider ownership Jul 10, 2025 Jul 8, 2025
4 Insider transaction Jul 9, 2025 Jul 7, 2025
4 Insider transaction Jul 9, 2025 Jul 7, 2025
4 Insider transaction Jul 9, 2025 Jul 7, 2025
4 Insider transaction Jul 9, 2025 Jul 7, 2025
4 Insider transaction Jul 9, 2025 Jul 7, 2025
4 Insider transaction Jul 1, 2025 Mar 31, 2025
4 Insider transaction Jun 23, 2025 Jun 20, 2025
4 Insider transaction Jun 23, 2025 Jun 20, 2025
4 Insider transaction Jun 23, 2025 Jun 20, 2025
4 Insider transaction Jun 23, 2025 Jun 20, 2025
8-K Current report
Officer or director change, Shareholder vote results
Jun 11, 2025 Jun 10, 2025
8-K Current report
Agreement ended
May 13, 2025 May 13, 2025
10-Q Quarterly report May 8, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 8, 2025 May 8, 2025
DEFA14A Additional proxy material Apr 28, 2025 —
ARS Annual report to shareholders Apr 25, 2025 Dec 31, 2024
DEF 14A Proxy statement Apr 25, 2025 Apr 25, 2025
PRE 14A Preliminary proxy statement Apr 15, 2025 Apr 15, 2025
8-K Current report
Material agreement, Regulation FD disclosure
Apr 9, 2025 Apr 8, 2025
10-K Annual report Mar 27, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 26, 2025 Mar 26, 2025
8-K Current report
Regulation FD disclosure, Other events
Mar 4, 2025 Mar 4, 2025
4 Insider transaction Feb 20, 2025 Feb 18, 2025
4 Insider transaction Feb 20, 2025 Feb 18, 2025
4 Insider transaction Feb 20, 2025 Feb 18, 2025
4 Insider transaction Feb 20, 2025 Feb 18, 2025
4 Insider transaction Feb 20, 2025 Feb 18, 2025
8-K Current report
Other events
Feb 3, 2025 Jan 28, 2025
8-K Current report
Officer or director change
Jan 24, 2025 Jan 17, 2025
4 Insider transaction Jan 22, 2025 Jan 17, 2025
4 Insider transaction Jan 22, 2025 Jan 17, 2025
4 Insider transaction Jan 22, 2025 Jan 17, 2025
4 Insider transaction Jan 22, 2025 Jan 17, 2025
4 Insider transaction Jan 22, 2025 Jan 17, 2025
4 Insider transaction Jan 7, 2025 Dec 31, 2024
4 Insider transaction Jan 7, 2025 Dec 31, 2024
8-K Current report
Regulation FD disclosure, Other events
Jan 7, 2025 Jan 7, 2025
8-K Current report
Material agreement, New debt, Regulation FD disclosure, Other events
Dec 23, 2024 Dec 20, 2024
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 7, 2024 Nov 7, 2024
8-K Current report
Other events
Oct 15, 2024 Oct 15, 2024
424B5 Prospectus supplement Oct 15, 2024 —
EFFECT Filing Oct 7, 2024 —
424B3 Prospectus Oct 7, 2024 —
S-1/A Amended registration statement Oct 7, 2024 —
8-K Current report
Other events
Oct 7, 2024 Oct 7, 2024
8-K Current report
Other events
Oct 4, 2024 Oct 4, 2024
CORRESP Letter to the SEC Oct 3, 2024 —
S-1/A Amended registration statement Oct 3, 2024 —
UPLOAD Letter from the SEC Oct 2, 2024 —
4 Insider transaction Oct 1, 2024 Sep 30, 2024
4 Insider transaction Oct 1, 2024 Sep 30, 2024
S-1 Registration statement Sep 27, 2024 —
8-K Current report
Officer or director change, Regulation FD disclosure, Other events
Sep 12, 2024 Sep 9, 2024
8-K Current report
Other events
Sep 10, 2024 Sep 9, 2024
424B5 Prospectus supplement Sep 3, 2024 —
8-K Current report
Other events
Sep 3, 2024 Sep 3, 2024
SC 13D/A Amended ownership over 5% (active) Aug 30, 2024 —
8-K Current report
Other events
Aug 29, 2024 Aug 28, 2024
8-K Current report
Shareholder vote results
Aug 28, 2024 Aug 28, 2024
EFFECT Filing Aug 27, 2024 —
424B3 Prospectus Aug 27, 2024 —
CORRESP Letter to the SEC Aug 26, 2024 —
UPLOAD Letter from the SEC Aug 26, 2024 —
DEFA14A Additional proxy material Aug 23, 2024 —
SC 13D/A Amended ownership over 5% (active) Aug 20, 2024 —
4 Insider transaction Aug 19, 2024 Aug 15, 2024
S-1 Registration statement Aug 19, 2024 —
8-K Current report
Other events
Aug 19, 2024 Aug 15, 2024
424B5 Prospectus supplement Aug 19, 2024 —
10-Q Quarterly report Aug 13, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 13, 2024 Aug 13, 2024
8-K Current report
Listing notice, Change to shareholder rights, Bylaw or fiscal year change
Aug 7, 2024 Aug 2, 2024
8-K Current report
Shareholder vote results
Jul 30, 2024 Jul 30, 2024
EFFECT Filing Jul 24, 2024 —
424B3 Prospectus Jul 24, 2024 —
DEF 14A Proxy statement Jul 22, 2024 Jul 22, 2024
CORRESP Letter to the SEC Jul 22, 2024 —
UPLOAD Letter from the SEC Jul 22, 2024 —
SC 13D/A Amended ownership over 5% (active) Jul 16, 2024 —
S-8 Employee stock plan registration Jul 15, 2024 —
S-3 Shelf registration Jul 15, 2024 —
PRE 14A Preliminary proxy statement Jul 12, 2024 Jul 12, 2024
DEFA14A Additional proxy material Jul 12, 2024 —
SC 13D/A Amended ownership over 5% (active) Jul 2, 2024 —
4 Insider transaction Jul 2, 2024 Jun 28, 2024
4 Insider transaction Jul 2, 2024 Jun 28, 2024
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights
Jul 1, 2024 Jun 28, 2024
DEF 14A Proxy statement Jun 28, 2024 Jun 28, 2024
SC 13D/A Amended ownership over 5% (active) Jun 27, 2024 —
PRE 14A Preliminary proxy statement Jun 18, 2024 Jun 18, 2024
8-K Current report
Listing notice
Jun 18, 2024 Jun 17, 2024
4 Insider transaction Jun 13, 2024 Jun 11, 2024
4 Insider transaction Jun 13, 2024 Jun 11, 2024
4 Insider transaction Jun 13, 2024 Jun 11, 2024
4 Insider transaction Jun 13, 2024 Jun 11, 2024
4 Insider transaction Jun 13, 2024 Jun 11, 2024
4 Insider transaction Jun 13, 2024 Jun 11, 2024
4 Insider transaction Jun 13, 2024 Jun 11, 2024

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
CING (Nasdaq), CINGW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Kansas City, KS
SEC filer status
, Emerging growth company
SEC CIK
1862150
Former names
Cingulate Inc. (until Oct 2, 2026)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.